We haven’t seen a groundswell of interest like this since the Internet boom. 

Over the last week alone, the No. 1 trading opportunity of the year returned an average gain of 48%.

  • OrganiGram Holdings (OGRMF) was up 67%
  • Canopy Growth (TWMJF) more than doubled
  • GW Pharmaceuticals (GWPH) jumped another 16%
  • Lifestyle Delivery (LDSYF) added 10%

And the run is far from over.

As new states just begin to legalize marijuana for medicinal and recreational purposes, we’re seeing incredible interest for related stocks.  Analysts believe the industry could balloon to $22 billion by 2020, and $50 billion by 2026. 

In fact, just last week, we recommended a trade on OrganiGram Holdings (OGRMF). 

Two days later, the stock was up 26%, we sold half our position.

The real impetus has been the rapidly changing and improving public opinion. 

According to Gallup polls, in 1995, just 25% of the nation wanted to see marijuana legalized. By 2005, that figure jumped to 36%.  By 2011, it soared to 50%.

Nowadays, according to Gallup, support is up to 60%, an all-time high.  When it comes to legalizing it for medicinal purposes, support is as high as 84%. 

That growing support could put pressure on even more states that have yet to legalize it. 

As a matter of fact, by 2018, New Jersey could legalize marijuana when the next Governor assumes office.  Assemblyman Michael Patrick Carroll recently sponsored a bill in the Assembly that could treat marijuana like tobacco products in the eyes of the government. 

If passed, it could allow marijuana to be sold to any one aged 19 or older in unlimited quantities in convenience stores. 

For an idea of growth potential, Colorado legalized the drug in January 2014.  Since then it has collected $135 million in state tax revenues.

Denver is the first city to approve a law allowing people to use marijuana in bars, restaurants and other public places as long as it isn’t smoked.

Such incredible interest in the marijuana industry has also helped to fuel a new IPO.

Around November 28th, Emblem Corporation (EMC) – a licensed cannabis producer based in Canada – is set to IPO on the TSX Venture.

In fact, the opportunity in Canada is just as impressive.

Health Minister Jane Philpott told the United Nations General Assembly that Canada would introduce legislation to legalize and regulate recreational marijuana in 2017.  That alone would open the door for it to be sold at pharmacies, even liquor stores.

With a population of 36 million, Canada offers a substantial potential market for companies, such as Emblem, Lifestyle Delivery Systems, OrganiGram and Canopy Growth. 

So much so, analysts have pegged a $3.6 billion first-year target with growth to $5.6 billion in the first five years just for Canada sales.

Controversial or not, smart investors – like you – are buying the “Green Gold Rush.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment